Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in mice

被引:6
|
作者
Jia, Shu [1 ]
Jin, Lianyu [2 ]
Cheng, Xiaoyan [3 ]
Wu, Jingyi [1 ]
Yao, Xiaokun [1 ]
Shao, Jingping [1 ]
Zhang, Congcong [1 ]
Cen, Danwei [1 ]
Cheng, Bin [1 ]
Wang, Jing [4 ]
Chen, Lei [1 ]
Yao, Xiaomin [1 ]
机构
[1] Zhejiang Pharmaceut Coll, Fac Pharm, 888 Yinxian Rd, Ningbo, Peoples R China
[2] Ningbo Yinzhou 2 Hosp, Ningbo, Peoples R China
[3] Beijing Ctr Phys & Chem Anal, Beijing, Peoples R China
[4] Ningbo Univ, Peoples Hosp, Ningbo, Peoples R China
关键词
Bicyclol; NASH; ER stress; autophagy; apoptosis; ENDOPLASMIC-RETICULUM STRESS; MECHANISM; INJURY; EPIDEMIOLOGY; PATHOGENESIS; INHIBITION; APOPTOSIS; FIBROSIS;
D O I
10.1080/03639045.2022.2106238
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background and objective: Non-alcoholic fatty liver disease (NAFLD) is a manifestation of the metabolic syndrome in the liver, and non-alcoholic steatohepatitis (NASH) represents its advanced stage. Bicyclol has protective activity against NAFLD in mice; however, the effect of bicyclol on high-fat diet (HFD)-induced NASH and its underlying molecular mechanism remains unknown particularly anti-endoplasmic reticulum (ER) stress and autophagic machinery potentials. Therefore, the present study was performed to investigate the protective effect and underlying mechanisms of bicyclol action on NAFLD/NASH. Methods: Mice were fed an HFD to induce NAFLD/NASH, and bicyclol was administered as a treatment. Biochemistry and histopathological assays were performed to evaluate the effects of bicyclol on NAFLD/NASH. Moreover, the levels of hepatic ER stress- and autophagy-related markers were determined by western blotting. Results: The present results revealed that bicyclol exerted significant protective effects against HFD-induced NAFLD/NASH. This activity was evidenced by the decrease in elevated serum transaminase and hepatic triglyceride levels, and the attenuation of negative histopathological changes. Bicyclol considerably alleviated hepatic inflammation and apoptosis. The protein expression of ER stress-related markers, including C/EBP homologous protein (CHOP) and glucose-regulated protein 78 (GRP78), was downregulated by the bicyclol treatment in HFD-induced mice. However, the protein expression of autophagy-related markers (LC3 and Beclin 1) was upregulated by the treatment with bicyclol. Conclusion: Bicyclol protected HFD-induced NASH, and partly due to its ability of reducing ER stress and promoting autophagy.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [32] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [33] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Cocciolillo, Sila
    Parruti, Giustino
    Marzio, Leonardo
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 496 - 503
  • [34] PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer
    Peyrou, Marion
    Bourgoin, Lucie
    Foti, Michelangelo
    DIGESTIVE DISEASES, 2010, 28 (01) : 236 - 246
  • [35] An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (08) : 759 - 772
  • [36] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    Weiner, R. A.
    DIGESTIVE DISEASES, 2010, 28 (01) : 274 - 279
  • [37] MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice
    Jiang, Weiwei
    Liu, Juan
    Dai, Yanyan
    Zhou, Nan
    Ji, Chenling
    Li, Xiaonan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (05) : 933 - 943
  • [38] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [39] Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway
    Niu, Meng-Yuan
    Dong, Geng-Ting
    Li, Yi
    Luo, Qing
    Cao, Liu
    Wang, Xi-Min
    Wang, Qi-Wen
    Wang, Yi-Ting
    Zhang, Zhe
    Zhong, Xi-Wen
    Dai, Wei-Bo
    Li, Le-Yu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (30)
  • [40] Perilipin 5 regulates hepatic stellate cell activation and high-fat diet-induced non-alcoholic fatty liver disease
    Xuecui Yin
    Lin Dong
    Xiaohan Wang
    Zhenzhen Qin
    Yuying Ma
    Xiaofei Ke
    Ya Li
    Qingde Wang
    Yang Mi
    Quanjun Lyu
    Xia Xu
    Pengyuan Zheng
    Youcai Tang
    Animal Models and Experimental Medicine, 2024, 7 (02) : 166 - 178